United Arab Emirates Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

United Arab Emirates Pharmaceuticals and Healthcare Report

United Arab Emirates Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
United Arab Emirates Pharmaceuticals and Healthcare Report
Published Oct 01, 2016
94 pages — Published Oct 01, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Introduction of comprehensive public sector insurance coverage is threatening to limit operations of private insurers among the expatriate population. The ministry s ban on private pharmacies offering discounts on pharmaceutical products will undercut their margins. A regional drug price harmonisation, as proposed by the Gulf Cooperation Council, will affect margins. An expansion of government cost-containment measures - most notably the implementation of extensive price cuts - is threatening to slow market development. Any fall in oil prices could result in a reduction in government industry investment, which could slow pharmaceutical market growth. ...An expansion of government cost-containment measures - most notably the implementation of extensive price cuts - is threatening to slow market development. Any fall in oil prices could result in a reduction in government industry investment, which could slow pharmaceutical market growth.

...BMI View: The UAE will remain one of the most attractive pharmaceutical and healthcare markets in the Middle East and Africa Region. A rising chronic disease burden will drive demand for high-value medicines, particularly cancer drugs. ...A rising chronic disease burden will drive demand for high-value medicines, particularly cancer drugs. The market is dominated by patented medicines, mainly imported from Western suppliers due to their perceived superiority. However, this current model is unsustainable over the long term and as such, the supply of generic cancer medicines in the UAE will increasingly be satisfied by the domestic industry, limiting the country s escalating healthcare costs. ...The market is dominated by patented medicines, mainly imported from Western suppliers due to their perceived superiority. However, this current model is unsustainable over the long term and as such, the supply of generic cancer medicines in the UAE will increasingly be satisfied by the domestic industry, limiting the country s escalating healthcare costs.

...In August ----, the Ministry of Health (MoH) reduced the prices of --- drugs from between ---- , including medicines for cardiovascular diseases, central nervous system disorders, infections, respiratory diseases, endocrine and others. In August ----, UAE-based Julphar reported a -.- y-o-y decline in sales revenue - amounting to AED---.-mn (USD---.-mn) - and a --.- y-o-y fall in net profits - recorded at AED---.-bn (USD---.-mn) for H---. ...

  
Source:
Document ID
1748-2275
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "United Arab Emirates Pharmaceuticals and Healthcare Report" Oct 01, 2016. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/United-Arab-Emirates-Pharmaceuticals-and-Healthcare-Report-2026-536>
  
APA:
Business Monitor International - Industry Reports. (2016). United Arab Emirates Pharmaceuticals and Healthcare Report Oct 01, 2016. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/United-Arab-Emirates-Pharmaceuticals-and-Healthcare-Report-2026-536>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.